The provision of current income tax of Gland Pharma Limited (''Gland Pharma''), a subsidiary of the Company incorporated in India, is based on a statutory rate of 25.17%. The provision of current income tax of Breas Medical Holdings AB (''Breas''), a subsidiary of the Company ...
Founded in 2010, Shanghai Henlius (2696.HK) aims to provide affordable and innovative biologic medicines for patients worldwide. In February 2019, HANLIKANG (rituximab injection) developed by Henlius has been approved by the National Medical Products Administration (NMPA) and became the first biosimi...
Attractive Placement Pricing Terms to Bring Capital for Business Development The Placing Price of HK$26.51 per H Share represents discount of approximately 4.98% to the closing price of HK$27.90 per H Share as quoted on the Stock Exchange on 26 March 2014, the last trading day prior to the ...